Juan Carlos López-Gil

6PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 03, 2024
Autofluorescent Cancer Stem Cells: Potential Biomarker to Predict Recurrence in Resected Colorectal Tumors.

Sonia Alcala, Gonzalo Serralta San Martin, Marta Muñoz-Fernández de Legaria

|May 16, 2024
The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.

Juan Carlos López-Gil, Susana García-Silva, Laura Ruiz-Cañas

|Feb 03, 2021
The CXCL12 Crossroads in Cancer Stem Cells and Their Niche.

Juan Carlos López-Gil, Laura Martin-Hijano, Patrick C Hermann

|Dec 08, 2020
Correction: Alcalá, S., et al. Targeting SRC Kinase Signaling in Pancreatic Cancer Stem Cells. Int. J. Mol. Sci. 2020, 21, 7437.

Sonia Alcalá, Víctor Mayoral-Varo, Laura Ruiz-Cañas

|Oct 14, 2020
Targeting SRC Kinase Signaling in Pancreatic Cancer Stem Cells.

Sonia Alcalá, Víctor Mayoral-Varo, Laura Ruiz-Cañas

|Mar 19, 2020
The Cancer Stem Cell in Hepatocellular Carcinoma.

Lucas-Alexander Schulte, Juan Carlos López-Gil, Bruno Sainz

Pageof 1